These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26867645)

  • 1. Antihypertensive treatments for adults with type 2 diabetes.
    Majumdar SR
    BMJ; 2016 Feb; 352():i560. PubMed ID: 26867645
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood pressure control in type 2 diabetes mellitus.
    Krantz MJ
    Ann Intern Med; 2004 Mar; 140(6):487; author reply 487-8. PubMed ID: 15023718
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative effectiveness of antihypertensive drugs in patients with diabetes.
    Wu HY; Hung KY; Tu YK; Chien KL
    J Comp Eff Res; 2014 May; 3(3):213-5. PubMed ID: 24969144
    [No Abstract]   [Full Text] [Related]  

  • 4. [Need of tight blood pressure control in type 2 diabetes. The intervention study ADVANCE gives clear information].
    Nilsson PM
    Lakartidningen; 2007 Oct 17-23; 104(42):3028-9. PubMed ID: 17985709
    [No Abstract]   [Full Text] [Related]  

  • 5. [Angiotensin II type-1 receptor antagonists and diabetes mellitus].
    Schnack C; Schernthaner G
    Wien Med Wochenschr; 2001; 151(7-8):165-8. PubMed ID: 11450165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trials that matter: the effect of a fixed-dose combination of an Angiotensin-converting enzyme inhibitor and a diuretic on the complications of type 2 diabetes.
    Bakris GL; Berkwits M
    Ann Intern Med; 2008 Mar; 148(5):400-1. PubMed ID: 18316758
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of high-risk diabetic patients with angiotensin II receptor blockers.
    Estacio R
    Diabetes Obes Metab; 2001 Dec; 3(6):472-6. PubMed ID: 11903421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACE inhibitors and antihypertensive treatment in diabetes: focus on microalbuminuria and macrovascular disease.
    Mogensen CE
    J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):234-9. PubMed ID: 11881030
    [No Abstract]   [Full Text] [Related]  

  • 9. CCBs vs ACE inhibitors in patients with diabetes.
    Zamorski MA
    J Fam Pract; 1998 Jul; 47(1):12-3. PubMed ID: 9673598
    [No Abstract]   [Full Text] [Related]  

  • 10. [Angiotensin converting enzyme inhibitors in the treatment of diabetes].
    Smahelová A
    Vnitr Lek; 2003 Dec; 49(12):948-51. PubMed ID: 15040161
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment and management of left ventricular hypertrophy in Type 2 diabetes patients with high blood pressure.
    Derosa G; Maffioli P
    Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):719-28. PubMed ID: 23750681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renoprotection with antihypertensive agents.
    Fournier A; Presne C; Makdassi R; Mazouz H; Choukroun G
    Lancet; 2002 May; 359(9318):1694-5. PubMed ID: 12020553
    [No Abstract]   [Full Text] [Related]  

  • 13. The Polypill and type 2 diabetes.
    Gale E
    Diabet Med; 2004 Jan; 21 Suppl 1():8-10. PubMed ID: 15088929
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of the renin-angiotensin system: added value in reducing cardiovascular and renal risk?
    Marshall SM
    Diabet Med; 2004 Jan; 21(1):1-3. PubMed ID: 14706047
    [No Abstract]   [Full Text] [Related]  

  • 15. Renin-angiotensin-system blockade in the prevention of diabetes.
    Ostergren J
    Diabetes Res Clin Pract; 2007 May; 76 Suppl 1():S13-21. PubMed ID: 17320999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE inhibitors or ARBs for diabetic nephropathy: the unrelenting debate.
    Kota SK; Meher LK; Jammula S; Kota SK; Modi KD
    Diabetes Metab Syndr; 2012; 6(4):215-7. PubMed ID: 23199543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive treatment and mortality in diabetic patients. What is the evidence?
    Sawicki PT; Heise T; Berger M
    Diabetologia; 1997 Jul; 40 Suppl 2():S134-7. PubMed ID: 9248721
    [No Abstract]   [Full Text] [Related]  

  • 18. Angiotensin-Converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers.
    Tazkarji B; Ganeshamoorthy A; Auten B
    Am Fam Physician; 2015 Feb; 91(3):193-4. PubMed ID: 25822274
    [No Abstract]   [Full Text] [Related]  

  • 19. Renin-angiotensin-aldosterone system blockade and urinary albumin excretion in community-based patients with Type 2 diabetes: the Fremantle Diabetes Study.
    Fegan PG; Davis WA; Kamber N; Sivakumar S; Beilby J; Davis TM
    Diabet Med; 2011 Jul; 28(7):849-55. PubMed ID: 21231957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress on the drug therapy for diabetic microangiopathies: RA system inhibitor].
    Higashiura K; Shimamoto K
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():144-9. PubMed ID: 15999698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.